| Ticker Details |
|
NORTHWEST BIOTHERAPEUTICS INC |
| IPO Date: |
January 1, 2002 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.11 | 3.88%
|
| Avg Daily Range (30 D): |
$0.01 | 3.01%
|
| Avg Daily Range (90 D): |
$0.01 | 5.32%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.93M |
| Avg Daily Volume (30 D): |
2.43M |
| Avg Daily Volume (90 D): |
3.3M |
| Trade Size |
| Avg Trade Size (Sh.): |
1,061 |
| Avg Trade Size (Sh.) (30 D): |
4,845 |
| Avg Trade Size (Sh.) (90 D): |
4,483 |
| Institutional Trades |
| Total Institutional Trades: |
49 |
| Avg Institutional Trade: |
$1.47M |
| Avg Institutional Trade (30 D): |
$.55M |
| Avg Institutional Trade (90 D): |
$.55M |
| Avg Institutional Trade Volume: |
.33M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$2.47M |
| Avg Closing Trade (30 D): |
$M |
| Avg Closing Trade (90 D): |
$M |
| Avg Closing Volume: |
617.26K |
|
|
| Financials |
| |
TTM |
Q1 2024 |
Q4 2016 |
|
Basic EPS
|
$-.02
|
$-.02
|
|
|
Diluted EPS
|
$-.02
|
$-.02
|
|
|
Revenue
|
$.23M
|
$.28M
|
$.07M
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
$-28.2M
|
$-18.3M
|
$-30.71M
|
|
Operating Income / Loss
|
$-18.5M
|
$-15.74M
|
$-21.25M
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
$-4.32M
|
$-.56M
|
$4.83M
|
|
PE Ratio
|
|
|
|
| Splits |
|
Sep 26, 2012
|
1:16
|
|
Jun 28, 2007
|
1:15
|
|
|
|
